Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial

被引:5
|
作者
Bichler, Carina S. [1 ]
Niedermeier, Martin [1 ]
Huefner, Katharina [2 ]
Galffy, Matyas [2 ]
Gostner, Johanna M. [3 ]
Nelles, Philipp [2 ]
Schoettl, Stefanie E. [1 ]
Sperner-Unterweger, Barbara [2 ]
Kopp, Martin [1 ]
机构
[1] Univ Innsbruck, Dept Sport Sci, Fuerstenweg 185, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Univ Hosp Psychiat 2, Dept Psychiat Psychotherapy Psychosomat & Med Psy, Anichstr 35, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Inst Med Biochem, Bioctr, Innrain 80-82, A-6020 Innsbruck, Austria
关键词
anxiety disorder; post-traumatic stress disorder; exercise; physical activity; climbing therapy; biomarker; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; PHYSICAL-ACTIVITY; SERUM TRYPTOPHAN; NORDIC WALKING; EXERCISE; PEOPLE; HEALTH; METAANALYSIS;
D O I
10.3390/ijerph191811622
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Exercise has considerable effects on physical and psychological health. Anxiolytic effects of climbing exercise have been found in people suffering from depression. However, there are no studies on patients with severe anxiety disorders or post-traumatic stress disorder (PTSD) practicing climbing as add-on treatment. Additionally, many studies on physical therapy fail to use adequate active control groups. Therefore, this study aimed to investigate the feasibility of a four-week climbing exercise program for patients with anxiety disorders or PTSD in comparison to a standard exercise treatment and a social control group. Methods: Outpatients diagnosed with anxiety disorders or PTSD (F 40, F 41, F 43.1 according to ICD-10) were randomly assigned to (a) climbing exercise (n = 27), (b) Nordic walking exercise (n = 23), or (c) control condition (n = 23) providing the same amount of social contact for eight sessions of 90 minutes each. Psychological parameters (symptom severity, worry symptoms, self-efficacy, quality of life) and biological parameters were assessed at the beginning and at the end of the four-week program. Additionally, follow-up assessments were conducted three and six months after the program ended. Results: Sixty outpatients (75% female) aged 18-65 years with a longstanding history of a mental disorder (>10 years) and classified as treatment-resistant (95%) and with averaging 3.8 psychiatric comorbidities completed the pilot trial. After participation, symptoms of anxiety disorders were significantly reduced (p = 0.003), and health-related characteristics significantly improved (depression symptoms: p < 0.001, worry symptoms: p < 0.001, self-efficacy: p < 0.001, quality of life-physical health: p = 0.002, quality of life-psychological health: p = 0.006) in all groups. The feasibility of conducting climbing exercises for the patient groups could be demonstrated, and a general acceptance in the groups was recorded. No significant time-by-group interactions were found. At the completion of the program, psychological parameters improved, while biological parameters remained the same in all three groups. Conclusions: Participation in the climbing group as well as in Nordic walking and social contact groups demonstrated beneficial results in patients with anxiety disorders and PTSD with severe mental burden. Nevertheless, climbing did not show any additional clinically relevant benefits compared to Nordic walking or social contact. Studies with larger sample sizes and qualitative insights are needed to further evaluate the possible benefits of climbing in this population.
引用
收藏
页数:18
相关论文
共 49 条
  • [1] Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment
    Zhang, Yunyan
    Liu, Wei-Qiao
    Hosseinpour, Zahra
    Pike, G. Bruce
    Cerchiaro, Graziela
    Greenfield, Jamie
    Yong, V. Wee
    Metz, Luanne M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 85
  • [2] REDUCING ANXIETY IN PATIENTS UNDERGOING FIRST-TIME COLONOSCOPY: A PILOT AND FEASIBILITY STUDY FOR RANDOMIZED CONTROLLED TRIAL
    Albashir, Siwar M.
    Durepos, Pamela
    Calo, Natalia Causada
    Mangat, Ramandeep
    Nowakowski, Matilda E.
    Kaasalainen, Sharon
    Anglin, Rebecca
    Moayyedi, Paul
    Armstrong, David
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB568 - AB569
  • [3] Reducing Anxiety in Patients Undergoing First-Time Colonoscopy: A Pilot and Feasibility Study for a Randomized Controlled Trial
    Albashir, Siwar
    Durepos, Pamela
    Causada-Calo, Natalia S.
    Mangat, Ramandeep S.
    Nowakowski, Matilda E.
    Kaasalanien, Sharon
    Anglin, Rebecca
    Moayyedi, Paul
    Armstrong, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1581 - S1581
  • [4] Retraction Note: The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders
    Vladimir Anatolevich Parfenov
    Pavel Rudolfovich Kamchatnov
    Dina Rustemovna Khasanova
    Enver Ibragimovich Bogdanov
    Tatiana Markovna Lokshtanova
    Aleksandr Vitalevich Amelin
    Natalya Nikolaevna Maslova
    Nataliia Vyacheslavovna Pizova
    Galina Nikolaevna Belskaya
    Evgeny Robertovich Barantsevich
    Gulsum Abdurahmanovna Duchshanova
    Saltanat Ualihanovna Kamenova
    Oleg Vladimirovich Kolokolov
    Alexey Borisovich Glazunov
    Scientific Reports, 12
  • [5] RETRACTED ARTICLE: The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders
    Vladimir Anatolevich Parfenov
    Pavel Rudolfovich Kamchatnov
    Dina Rustemovna Khasanova
    Enver Ibragimovich Bogdanov
    Tatiana Markovna Lokshtanova
    Aleksandr Vitalevich Amelin
    Natalya Nikolaevna Maslova
    Nataliia Vyacheslavovna Pizova
    Galina Nikolaevna Belskaya
    Evgeny Robertovich Barantsevich
    Gulsum Abdurahmanovna Duchshanova
    Saltanat Ualihanovna Kamenova
    Oleg Vladimirovich Kolokolov
    Alexey Borisovich Glazunov
    Scientific Reports, 11
  • [6] Chinese Herbal Medicine Treatment Based on Subgroup Differentiation as Adjunct Therapy for Parkinson's Disease: Interim Analysis of a Pilot Add-on, Randomized, Controlled, Pragmatic Clinical Trial
    Yuen, S.
    Chua, K. K.
    Zhong, L.
    Chan, K. W.
    Chan, C.
    Ho, C. P.
    Chan, K. L.
    Han, E.
    Pang, K.
    Lin, Z. X.
    Mok, V.
    Cheung, N.
    Lau, A. Y.
    Li, M.
    MOVEMENT DISORDERS, 2023, 38 : S61 - S61
  • [7] Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial
    Louthrenoo, Worawit
    Nilganuwong, Surasak
    Nanagara, Ratanavadee
    Siripaitoon, Boonjing
    Basset, Sabine Collaud
    CLINICAL RHEUMATOLOGY, 2019, 38 (09) : 2461 - 2471
  • [8] Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial
    Worawit Louthrenoo
    Surasak Nilganuwong
    Ratanavadee Nanagara
    Boonjing Siripaitoon
    Sabine Collaud Basset
    Clinical Rheumatology, 2019, 38 : 2461 - 2471
  • [9] Cognitive bias modification as an add-on treatment in clinical depression: Results from a placebo-controlled, single-blinded randomized control trial
    Vrijsen, Janna N.
    Fischer, Verena S.
    Muller, Bernhard W.
    Scherbaum, Norbert
    Becker, Eni S.
    Rinck, Mike
    Tendolkar, Indira
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 238 : 342 - 350
  • [10] Coenzyme Q10 as a potential add-on treatment for patients suffering from painful diabetic neuropathy: results of a placebo-controlled randomized trial
    Paryan Amini
    Firozeh Sajedi
    Mahtabalsadat Mirjalili
    Younes Mohammadi
    Maryam Mehrpooya
    European Journal of Clinical Pharmacology, 2022, 78 : 1899 - 1910